<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=euc-jp" />
<meta http-equiv="content-style-type" content="text/css" />
<meta http-equiv="content-script-type" content="text/javascript" />

<title>Past Issues | YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;</title>

<meta name="Description" content="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" />
<meta name="Keywords" content="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" />
<meta http-equiv="imagetoolbar" content="no" />
<link rel="stylesheet" type="text/css" media="all" href="../../css/style.css" />
<link rel="stylesheet" type="text/css" media="all" href="../../css/en.css" />
<script type="text/javascript" src="../../js/jquery.js"></script>
<script type="text/javascript" src="../../js/jquery.function.js"></script>
</head>

<body class="page">
<div id="container">

<div id="header">
<p id="siteLogo"><a href="../../en.html"><img src="../../img/common/logo_en.gif" alt="YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;" width="437" height="28" /></a></p>
<p id="tagline"> YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot; is the private medical supply supervisory system.</p>
<div id="navUtility">
<ul>
<li><a href="../sitemap.html">Sitemap</a></li>
<li><a href="../../index.html">Japanese</a></li>
</ul>
<!-- /#navUtility --></div>
<div id="searchArea">
<form name="form1" action="http://www.yakugai.gr.jp/en/search.php" method="post">
<p><input id="searchInput" name="keyword" type="text" />&nbsp;<input value="Search" type="submit" /></p>
</form>
<!-- /#searchInput --></div>
<!-- /#header --></div>

<div id="nav">
<ul>
<li id="navHome"><a href="../../en.html">Home</a></li>
<li><a href="../about.html">About Us</a></li>
<li><a href="../activity.html">Activities</a></li>
<li class="current"><a href="../inve.html">Past Issues</a></li>
<li><a href="../about/about_links.html">Links</a></li>
</ul>
<!-- /#nav --></div>

<div class="inve" id="pageTitle">
<h1>Past Issues</h1>
<!-- /#pageTitle --></div>

<div id="topicPath">
<ol>
<li id="topicPathHome"><a href="../../en.html">Home</a></li>
<li>Past Issues</li>
</ol>
<!-- /#topicPath --></div>

<div id="contents">
<div id="main">
<h2>Champix (varenicline tartrate)</h2>

<div id="inveArticle"><p>
Champix is widely used in Japan as an aid to smoking cessation treatment.<br />
<br />
However, a significant number of neuropsychiatric symptoms have been observed, including changes in behavior, agitation, depressed mood, suicidal thoughts and suicidal behavior. <br />
<br />
Nevertheless, these harmful events were not written in the warning section of Japanese Prescription Information.<br />
On the other hand, the information excessively suggests that these symptoms may have resulted from the smoking cessation itself. <br />
<br />
Therefore, on July 6th 2009, we submitted a written request to the Ministry of Health, Labour and Welfare (MHLW) and Pfizer Japan to revise the package insert, to make a comprehensive effort to improve methods of assessing and monitoring the risks associated with drugs and biological products as per the US Food and Drug Administration (FDA), and to implement pharmacoepidemiological research immediately to clarify the causal relationship between Champix and psychoneurotic disorders, focusing on chronological sequence and dosage.<br />
<br />
On August 7th 2009, after the submission of our written request, the MHLW requested that Pfizer Japan revise Paxil¡Çs package insert.  As a result, the warning section on the package insert was revised.  <br />
<br />
The revised ¡ÈWarnings¡É state that the adverse events mentioned above have been reported. <br />
But the opening sentence adds that ¡Èquitting smoking is reported to be associated with various symptoms regardless of treatment, and sometimes worsens underlying psychiatric diseases¡É.<br />
On the other hand, it does not specify that some of these symptoms have occurred in patients taking Champix who continued to smoke.<br />
There is also no advice in the ¡ÈWarnings¡Ésection that the patient should stop taking Champix and contact a health care provider immediately if neuropsychiatric symptoms are observed.<br />
<br />
The revised ¡ÈWarnings¡Éon the package insert for Champix are still insufficient.<br />
<br />
Thus, on December 28th 2009, we submitted written requests once again to the MHLW and Pfizer Japan urging more adequate revisions of the package insert.<!-- /#inveArticle --></p></div>

<div class="sectionList" >
<h3>Topics</h3>
<ul class="ex">
<li class="person">YAKUGAI Ombudsperson</li>
<li class="tieup">Tie-up Group</li>
</ul>
<dl><dt>2009-12-28</dt>
<dd class="person">
<a href="../topics/topic.php@id=737.html">Champix(varenicline) : Submission of written requests once again to the MHLW and Pfizer Japan urging more adequate revisions of the package insert</a>
</dd>
<dt>2009-07-06</dt>
<dd class="person">
<a href="../topics/topic.php@id=646.html">Champix (varenicline): Submission of a written request about the safety measures of the smoking cessation drug Champix.</a>
</dd>
</dl><!-- /.sectionList -->
</div>
<!-- /#main --></div>

<div id="sub">
<h2>Table Of Contents</h2>
<div id="navSub">
<ul>
<li><a href="index.php.html#inveDrug">Drugs</a></li>
<li><a href="index.php.html#inveSystem">Systems</a></li>
</ul>
<!-- /#navSub --></div>
<!-- /#sub --></div>
<!-- /#contents --></div>

<div id="footer">
<p id="siteAdress">YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot; Tie-up group<br />
160-0022¡¡Tokyo Shinjuku Ward Shinjuku 1-14-4  AM building<br />
TEL : 03¡Ê3350¡Ë0607¡¡FAX : 03¡Ê5363¡Ë7080<br />
Mail : <a href="mailto:info@yakugai.gr.jp">&#105;&#110;&#102;o&#64;y&#97;&#107;u&#103;&#97;&#105;&#46;&#103;r.&#106;&#112;</a></p>

<div id="footerInner">
<ul id="navFooter">
<li><a href="../privacy.html">Privacy Policy</a></li>
</ul>
<p id="siteInfo">Our members have other regular jobs and volunteer their services free of charge. Our secretariat also serves as part-time basis, and we are currently in the process of facilitating the secretariat function. Therefore, please note that due to limited resources, we might not be able to respond to each inquiry on specific medicine. Thank you for your understanding.</p>
<p id="copyright"><img src="../../img/common/copyright.gif" alt="Copyright (c) YAKUGAI Ombudsperson &quot;Medwatcher Japan&quot;. all rights reserved." width="419" height="11" /></p>
<!-- /#footerInner --></div>

<!-- /#footer --></div>

<!-- /#container --></div>

<!-- google Analytics -->
<script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
<script type="text/javascript">
try {
var pageTracker = _gat._getTracker("UA-11615542-1");
pageTracker._trackPageview();
} catch(err) {}
</script>
<!-- /google Analytics -->
<!-- nakanohito -->
<script LANGUAGE="Javascript">
<!--
var refer = document.referrer;
document.write("<a href='http://nakanohito.jp/'>");
document.write("<img src='http://nakanohito.jp/an/?u=202528&h=897479&w=48&guid=ON&t=&version=js&refer="+escape(parent.document.referrer)+"&url="+escape(parent.document.URL)+"' border='0' width='48' height='48' />");
document.write("</a>");
//-->
</script>
<noscript>
<img src="http://nakanohito.jp/an/?u=202528&h=897479&w=48&guid=ON&t=" width="48" height="48" alt="" border="0" />
</noscript>
<!-- nakanohito end -->

</body>
</html>
